Basic Information

Common Name
B-hEFEMP1 MC38
Catalog Number
321926
Alias
DHRD; DRAD; FBNL; MLVT; MTLV; S1-5; FBLN3; FIBL-3
Disease
Colon carcinoma
Organism
Mouse
Strain
C57BL/6
Tissue
Colon
Application
B-hEFEMP1 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Description

The mouse Efemp1 gene was replaced by human EFEMP1 coding sequence in B-hEFEMP1 MC38 cells. Human EFEMP1 is highly expressed on the supernatant of B-hEFEMP1 MC38 cells. B-hEFEMP1 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

Gene targeting strategy

Gene targeting strategy for B-hEFEMP1 MC38 cells. The exogenous promoter and human EFEMP1 coding sequence was inserted to replace part of murine exon 4. The insertion disrupts the endogenous murine Efemp1 gene, resulting in a non-functional transcript.

Protein expression analysis

EFEMP1 expression analysis in B-hEFEMP1 MC38 cells by western blot. Human EFEMP1 was detected in the supernatant of B-hEFEMP1 MC38 cells but not wild-type MC38 cells. The 2-F12 clone of B-hEFEMP1 MC38 cells was used for in vivo experiments.

Tumor growth curve and body weight changes

Subcutaneous homograft tumor growth of B-hEFEMP1 MC38 cells. B-hEFEMP1 MC38 cells (5×106) and wild-type MC38 cells (5×105) were subcutaneously implanted into C57BL/6 mice (female, 9-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B)  Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hEFEMP1 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

Back to top